FDA Inspection 972342 — Velocity Pharma LLC

Velocity Pharma LLC — FEI 2000044401

The FDA completed an inspection of Velocity Pharma LLC on May 18, 2016 in Melville, NY. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 6 citations were issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
May 18, 2016
Fiscal Year
2016
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Melville, NY (United States)

Citations

IDCFRDescription
154021 CFR 211.125(a)Strict control not exercised over labeling issued
162921 CFR 211.130(a)Prevention of cross contamination, mix-ups
163621 CFR 211.130(e)Packaging line inspection before use
163721 CFR 211.130(e)Packaging line inspection after use
361321 CFR 211.160(b)(4)Establishment of calibration procedures
432621 CFR 211.122(g)(2)Electronic or electromechanical equipment